- Home
- OBIO vs CBFV Comparison
OBIO vs CBFV Comparison
Compare OBIO & CBFV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- CBFV
- Stock Information
- Founded
- OBIO 2017
- CBFV 1901
- Country
- OBIO United States
- CBFV United States
- Employees
- OBIO N/A
- CBFV N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- CBFV Major Banks
- Sector
- OBIO Health Care
- CBFV Finance
- Exchange
- OBIO Nasdaq
- CBFV Nasdaq
- Market Cap
- OBIO 151.3M
- CBFV 148.0M
- IPO Year
- OBIO N/A
- CBFV N/A
- Fundamental
- Price
- OBIO $2.65
- CBFV $29.09
- Analyst Decision
- OBIO Strong Buy
- CBFV Hold
- Analyst Count
- OBIO 5
- CBFV 2
- Target Price
- OBIO $14.20
- CBFV $26.00
- AVG Volume (30 Days)
- OBIO 959.6K
- CBFV 17.3K
- Earning Date
- OBIO 05-16-2025
- CBFV 04-23-2025
- Dividend Yield
- OBIO N/A
- CBFV 3.38%
- EPS Growth
- OBIO N/A
- CBFV N/A
- EPS
- OBIO N/A
- CBFV 1.92
- Revenue
- OBIO $2,638,000.00
- CBFV $48,630,000.00
- Revenue This Year
- OBIO $13.87
- CBFV $8.55
- Revenue Next Year
- OBIO $32.19
- CBFV $9.01
- P/E Ratio
- OBIO N/A
- CBFV $15.42
- Revenue Growth
- OBIO N/A
- CBFV N/A
- 52 Week Low
- OBIO $2.43
- CBFV $20.75
- 52 Week High
- OBIO $8.87
- CBFV $33.72
- Technical
- Relative Strength Index (RSI)
- OBIO 43.61
- CBFV 52.84
- Support Level
- OBIO $2.37
- CBFV $29.24
- Resistance Level
- OBIO $2.99
- CBFV $30.54
- Average True Range (ATR)
- OBIO 0.33
- CBFV 0.49
- MACD
- OBIO 0.05
- CBFV 0.03
- Stochastic Oscillator
- OBIO 32.18
- CBFV 22.04
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.